Tearsheet

CNO Financial (CNO)


Market Price (3/13/2026): $39.48 | Market Cap: $3.8 Bil
Sector: Financials | Industry: Life & Health Insurance

CNO Financial (CNO)


Market Price (3/13/2026): $39.48
Market Cap: $3.8 Bil
Sector: Financials
Industry: Life & Health Insurance

Investment Highlights Why It Matters Detailed financial logic regarding cash flow yields vs trend-riding momentum.

0 Attractive yield
Total YieldTotal Yield = Earnings Yield + Dividend Yield, Earnings Yield = Net Income / Market Cap Dividend Yield = Total Dividends / Market Cap is 7.6%, ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is 3.6%, FCF Yield is 18%
Weak multi-year price returns
3Y Excs Rtn is -1.4%
Key risks
CNO key risks include [1] an acute earnings sensitivity to both high and low interest rate environments due to its specific liabilities from embedded derivatives and annuities.
1 Cash is significant % of market cap
Net D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is -120%
  
2 Attractive cash flow generation
CFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 15%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is 15%
  
3 Low stock price volatility
Vol 12M is 29%
  
4 Megatrend and thematic drivers
Megatrends include Aging Population & Chronic Disease, and Fintech & Digital Payments. Themes include Geriatric Care, Online Banking & Lending, Show more.
  
0 Attractive yield
Total YieldTotal Yield = Earnings Yield + Dividend Yield, Earnings Yield = Net Income / Market Cap Dividend Yield = Total Dividends / Market Cap is 7.6%, ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is 3.6%, FCF Yield is 18%
1 Cash is significant % of market cap
Net D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is -120%
2 Attractive cash flow generation
CFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 15%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is 15%
3 Low stock price volatility
Vol 12M is 29%
4 Megatrend and thematic drivers
Megatrends include Aging Population & Chronic Disease, and Fintech & Digital Payments. Themes include Geriatric Care, Online Banking & Lending, Show more.
5 Weak multi-year price returns
3Y Excs Rtn is -1.4%
6 Key risks
CNO key risks include [1] an acute earnings sensitivity to both high and low interest rate environments due to its specific liabilities from embedded derivatives and annuities.

Valuation, Metrics & Events

Price Chart

Why The Stock Moved

Qualitative Assessment

AI Analysis | Feedback

CNO Financial (CNO) stock has remained largely at the same level since 11/30/2025 because of the following key factors:

1. Strong Q4 2025 Earnings Beat and Full-Year Performance.

CNO Financial reported robust financial results for the fourth quarter and full year 2025. The company's Q4 2025 operating earnings per share (EPS) reached $1.47, significantly surpassing the Zacks Consensus Estimate of $1.20, representing a 22.50% positive surprise. This strong quarterly performance contributed to a full-year 2025 operating EPS of $4.40, marking an 11% increase from the prior year. Additionally, Q4 2025 revenue of $1.17 billion exceeded the Zacks Consensus Estimate of $1.01 billion.

2. Consistent Sales Growth and Operational Momentum.

The company demonstrated sustained operational strength with its 14th consecutive quarter of strong insurance sales, achieving a record 15% growth in total new annualized premiums (NAP) for the full year 2025. This growth was observed across both its Consumer and Worksite divisions. Furthermore, client assets in brokerage and advisory services increased by 24% year-over-year, and the company reported continued growth in its producing agent count.

Show more

Stock Movement Drivers

Fundamental Drivers

The -2.0% change in CNO stock from 11/30/2025 to 3/12/2026 was primarily driven by a -29.6% change in the company's Net Income Margin (%).
(LTM values as of)113020253122026Change
Stock Price ($)40.5939.77-2.0%
Change Contribution By: 
Total Revenues ($ Mil)4,4424,4871.0%
Net Income Margin (%)7.0%4.9%-29.6%
P/E Multiple12.617.135.7%
Shares Outstanding (Mil)97951.5%
Cumulative Contribution-2.0%

LTM = Last Twelve Months as of date shown

Market Drivers

11/30/2025 to 3/12/2026
ReturnCorrelation
CNO-2.0% 
Market (SPY)-2.5%43.1%
Sector (XLF)-8.4%70.7%

Fundamental Drivers

The 2.1% change in CNO stock from 8/31/2025 to 3/12/2026 was primarily driven by a 32.4% change in the company's P/E Multiple.
(LTM values as of)83120253122026Change
Stock Price ($)38.9739.772.1%
Change Contribution By: 
Total Revenues ($ Mil)4,3824,4872.4%
Net Income Margin (%)6.8%4.9%-27.3%
P/E Multiple12.917.132.4%
Shares Outstanding (Mil)99953.6%
Cumulative Contribution2.1%

LTM = Last Twelve Months as of date shown

Market Drivers

8/31/2025 to 3/12/2026
ReturnCorrelation
CNO2.1% 
Market (SPY)3.5%33.5%
Sector (XLF)-9.3%67.4%

Fundamental Drivers

The -2.6% change in CNO stock from 2/28/2025 to 3/12/2026 was primarily driven by a -47.9% change in the company's Net Income Margin (%).
(LTM values as of)22820253122026Change
Stock Price ($)40.8139.77-2.6%
Change Contribution By: 
Total Revenues ($ Mil)4,4464,4870.9%
Net Income Margin (%)9.5%4.9%-47.9%
P/E Multiple10.017.171.3%
Shares Outstanding (Mil)103958.0%
Cumulative Contribution-2.6%

LTM = Last Twelve Months as of date shown

Market Drivers

2/28/2025 to 3/12/2026
ReturnCorrelation
CNO-2.6% 
Market (SPY)13.1%65.9%
Sector (XLF)-5.4%78.1%

Fundamental Drivers

The 65.8% change in CNO stock from 2/28/2023 to 3/12/2026 was primarily driven by a 292.4% change in the company's P/E Multiple.
(LTM values as of)22820233122026Change
Stock Price ($)23.9939.7765.8%
Change Contribution By: 
Total Revenues ($ Mil)3,5774,48725.5%
Net Income Margin (%)17.6%4.9%-72.0%
P/E Multiple4.417.1292.4%
Shares Outstanding (Mil)1149520.3%
Cumulative Contribution65.8%

LTM = Last Twelve Months as of date shown

Market Drivers

2/28/2023 to 3/12/2026
ReturnCorrelation
CNO65.8% 
Market (SPY)74.3%56.4%
Sector (XLF)43.0%75.6%

Return vs. Risk

Price Returns Compared

 202120222023202420252026Total [1]
Returns
CNO Return10%-2%25%36%16%-6%101%
Peers Return8%22%16%32%1%-7%89%
S&P 500 Return27%-19%24%23%16%-1%80%

Monthly Win Rates [3]
CNO Win Rate58%42%58%50%83%0% 
Peers Win Rate62%52%60%65%53%40% 
S&P 500 Win Rate75%42%67%75%67%33% 

Max Drawdowns [4]
CNO Max Drawdown-5%-29%-10%-9%-4%-6% 
Peers Max Drawdown-10%-14%-11%-13%-13%-9% 
S&P 500 Max Drawdown-1%-25%-1%-2%-15%-2% 


[1] Cumulative total returns since the beginning of 2021
[2] Peers: GL, AFL, UNM, PRI, KMPR.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2026 data is for the year up to 3/12/2026 (YTD)

How Low Can It Go

Unique KeyEventCNOS&P 500
2022 Inflation Shock2022 Inflation Shock  
2022 Inflation Shock% Loss% Loss-39.8%-25.4%
2022 Inflation Shock% Gain to Breakeven% Gain to Breakeven66.0%34.1%
2022 Inflation ShockTime to BreakevenTime to Breakeven525 days464 days
2020 Covid Pandemic2020 Covid Pandemic  
2020 Covid Pandemic% Loss% Loss-54.2%-33.9%
2020 Covid Pandemic% Gain to Breakeven% Gain to Breakeven118.5%51.3%
2020 Covid PandemicTime to BreakevenTime to Breakeven231 days148 days
2018 Correction2018 Correction  
2018 Correction% Loss% Loss-47.6%-19.8%
2018 Correction% Gain to Breakeven% Gain to Breakeven90.7%24.7%
2018 CorrectionTime to BreakevenTime to Breakeven812 days120 days
2008 Global Financial Crisis2008 Global Financial Crisis  
2008 Global Financial Crisis% Loss% Loss-98.8%-56.8%
2008 Global Financial Crisis% Gain to Breakeven% Gain to Breakeven8061.5%131.3%
2008 Global Financial CrisisTime to BreakevenTime to Breakeven2,899 days1,480 days

Compare to GL, AFL, UNM, PRI, KMPR

In The Past

CNO Financial's stock fell -39.8% during the 2022 Inflation Shock from a high on 5/17/2021. A -39.8% loss requires a 66.0% gain to breakeven.

Preserve Wealth

Limiting losses and compounding gains is essential to preserving wealth.

Asset Allocation

Actively managed asset allocation strategies protect wealth. Learn more.

About CNO Financial (CNO)

CNO Financial Group, Inc., through its subsidiaries, develops, markets, and administers health insurance, annuity, individual life insurance, and other insurance products for senior and middle-income markets in the United States. It offers Medicare supplement, supplemental health, and long-term care insurance policies; life insurance; and annuities, as well as Medicare advantage plans to individuals through phone, online, mail, and face-to-face. The company also focuses on worksite and group sales for businesses, associations, and other membership groups by interacting with customers at their place of employment. In addition, it provides fixed index annuities; fixed interest annuities, including fixed rate single and flexible premium deferred annuities; single premium immediate annuities; supplemental health products, such as specified disease, accident, and hospital indemnity products; and long-term care plans primarily to retirees and older self-employed individuals in the middle-income market. Further, the company offers universal life and other interest-sensitive life products; and traditional life policies that include whole life, graded benefit life, term life, and single premium whole life products, as well as graded benefit life insurance products. CNO Financial Group, Inc. markets its products under the Bankers Life, Washington National, and Colonial Penn brand names. The company sells its products through agents, independent producers, and direct marketing. CNO Financial Group, Inc. was founded in 1979 and is headquartered in Carmel, Indiana.

AI Analysis | Feedback

A **Prudential** for pre-retiree and retiree insurance and annuities.

A **Lincoln Financial Group** specializing in insurance and annuities for middle-income seniors.

AI Analysis | Feedback

  • Life Insurance: Provides financial protection to beneficiaries upon the policyholder's death.
  • Supplemental Health Insurance: Offers coverage for specific health needs such as critical illness, accidents, or hospital stays, complementing major medical plans.
  • Annuities: Provides a guaranteed stream of income, primarily for retirement savings and distribution.

AI Analysis | Feedback

CNO Financial Group, Inc. (CNO) is an insurance holding company that primarily sells its products directly to individuals rather than to other companies.

The company serves the following categories of individual customers:

  • Middle-income seniors and pre-retirees: This customer segment, primarily served by CNO's Bankers Life and Colonial Penn brands, seeks a range of products including life insurance, health insurance (such as Medicare supplement and long-term care), and annuities to manage healthcare costs, protect assets, and ensure financial security during retirement.

  • Working individuals: Through its Washington National brand, CNO serves working individuals who are often seeking supplemental health insurance products (such as critical illness, accident, and short-term disability) and basic life insurance. These products are frequently offered through employer-sponsored worksite marketing programs or directly to individuals.

AI Analysis | Feedback

  • Tata Consultancy Services (TCS.NS)
  • Ernst & Young LLP
  • Wilton Re Ltd.

AI Analysis | Feedback

Gary C. Bhojwani, Chief Executive Officer

Gary C. Bhojwani became chief executive officer of CNO Financial Group on January 1, 2018, having previously served as president of the company from April 2016 through December 2017. Prior to joining CNO, Mr. Bhojwani was a member of the Board of Management of Allianz SE and chairman of Allianz of America, Allianz Life Insurance Company, and Fireman's Fund Insurance Company from 2012 to 2015. He was chief executive officer of Allianz Life Insurance Company of North America from 2007 through 2012 and president of Commercial Business, Fireman's Fund Insurance Company from 2004 to 2007. Mr. Bhojwani was also chief executive officer of Lincoln General Insurance Company from 2002 to 2004, and he founded and was chief executive officer of Avalon Risk Management from 1998 to 2002. He holds a Bachelor of Science degree in actuarial science from the University of Illinois and an MBA from the University of Chicago.

Paul H. McDonough, Chief Financial Officer

Paul H. McDonough was named chief financial officer for CNO Financial Group in March 2019. He brings nearly thirty years of public company finance and twenty years of insurance industry expertise to CNO. Prior to joining CNO, he served as executive vice president and chief financial officer of OneBeacon Insurance Group from 2005 to 2017, where he was instrumental in completing the company's successful IPO and executing a corporate restructuring. Previously, Mr. McDonough was chief financial officer at BJ's Wholesale Club in 2005 and held treasury roles at The St. Paul Companies from 1999 to 2004. He also worked in strategic planning and finance at Sears and Chevron, and proudly served as an officer in the U.S. Navy and Navy Reserve for six years. Mr. McDonough earned a bachelor's degree in government from Georgetown University and an MBA from the Kellogg Graduate School of Management at Northwestern University.

Karen J. DeToro, Chief Actuary and Chief Risk Officer

Karen J. DeToro has served as chief actuary of CNO Financial Group since September 2019 and was named chief risk officer in June 2020. Before joining CNO, DeToro held executive leadership positions in finance operations, product development, underwriting, strategy, and governance at New York Life, including serving as vice president and chief actuary of New York Life Direct. She was also a principal at Deloitte Consulting, where she led its Insurance Enterprise Risk Management (ERM) and Actuarial Transformation initiatives.

Eric R. Johnson, Chief Investment Officer and President, 40|86 Advisors, Inc.

Eric R. Johnson serves as the Chief Investment Officer of CNO Financial Group and President of 40|86 Advisors, Inc.

Joel Koehneman, Chief Accounting Officer

Joel Koehneman was appointed chief accounting officer of CNO Financial Group, effective January 25, 2025. He most recently served as a finance director at CDW Corporation. Mr. Koehneman has over 16 years of experience in the audit practice of PricewaterhouseCoopers (PwC), primarily focusing on life insurance clients, including serving as lead director on two life insurance company audits.

AI Analysis | Feedback

Here are the key risks to CNO Financial:

  1. Interest Rate Fluctuations: CNO Financial is highly sensitive to changes in interest rates. A prolonged low interest rate environment can reduce the net spread between the interest earned on investments and the interest credited to policyholders, impacting profitability. Conversely, a prolonged high-rate environment could depress earnings, as the company's embedded derivatives and annuity liabilities are acutely sensitive to Federal Reserve policy. Interest rate changes also directly affect the value of CNO's investment portfolio and influence policyholder behavior.

  2. Investment Portfolio Performance and Market Volatility: The company faces risks related to its investment portfolio, including potential unrealized losses that could pressure book value if interest rates rise further or credit quality deteriorates. Losses on investments can reduce the returns credited to customers, negatively affecting sales and financial performance. CNO's business is exposed to the performance of debt and equity markets, and adverse market conditions can impact the liquidity and value of its investments. Furthermore, persistent inflation poses risks to investment values.

  3. General Economic Conditions and Regulatory Environment: As an insurance provider, CNO Financial is exposed to broader economic cycles and regulatory changes. General economic factors, such as credit availability, consumer spending, business investment, and inflation, can depress demand for insurance products, leading to higher policy lapses or surrenders during economic downturns. The company also faces challenges from regulatory compliance and potential changes in tax laws, which could impact its operations and financial stability.

AI Analysis | Feedback

The clear emerging threat to CNO Financial comes from the accelerating rise of digital-first, direct-to-consumer (DTC) platforms and Insurtech companies specifically targeting the middle-income pre-retiree and retiree market for life, health, and annuity products. These emerging competitors leverage advanced digital marketing, artificial intelligence, and streamlined online application processes to offer a potentially lower-cost and more convenient alternative to CNO's traditional agent-centric (Bankers Life) and traditional direct-response (Colonial Penn) distribution models. This shift directly challenges CNO's established distribution advantages by appealing to an increasingly digitally savvy older demographic, threatening to erode market share and pricing power through more efficient customer acquisition and reduced overhead.

AI Analysis | Feedback

Product/Service Addressable Market Size Region
Health Insurance (Overall U.S.) USD 1.57 trillion (2025) U.S.
Medicare Supplement Health Insurance USD 39.1 billion (2024) U.S.
Long-Term Care Private Insurance USD 25.6 billion (2025) U.S.
Life Insurance USD 1.46 trillion (2024) U.S.
Annuities Over USD 430 billion (2024) U.S.
Financial Services (Wealth Management Solutions) null null
Workforce Benefits Solutions null null

AI Analysis | Feedback

Here are 3-5 expected drivers of future revenue growth for CNO Financial (symbol: CNO) over the next 2-3 years:
  1. Sustained Sales Momentum in Consumer and Worksite Divisions: CNO Financial anticipates continued robust growth in new annualized premiums across both its Consumer and Worksite Divisions. This includes strong performance in direct-to-consumer life insurance sales, which have seen significant surges, and consistent increases in Worksite Life and Health New Annualized Premiums. The company's strategic focus on the middle-income market further underpins this growth.
  2. Expansion of Annuity and Financial Advisory Products: Growth in collected annuity premiums and client assets in brokerage and advisory services is expected to contribute to revenue expansion. CNO Financial has demonstrated a consistent upward trend in these areas, reflecting strong demand for retirement and financial planning solutions.
  3. Product Innovation and Enhanced Offerings: CNO Financial is committed to launching innovative products and improving its existing portfolio. This strategy aims to capture future insurance premium growth by meeting evolving customer needs, as exemplified by the introduction and anticipated improvement in products like Optavise Clear, which bundles existing services with new Medicare advocacy and improved technology.
  4. Strategic Repositioning through Bermuda Treaty and Business Exit: The execution of a second Bermuda treaty and the strategic exit from the Worksite fee services business are expected to accelerate operating return on equity (ROE) improvement. While not a direct revenue driver, this streamlining and enhanced capital efficiency allow the company to sharpen its focus on higher-growth, more profitable core insurance offerings, indirectly supporting revenue growth.
  5. Favorable Demographic Trends: An aging U.S. population presents a significant tailwind for CNO Financial. The increasing number of Americans entering retirement age drives strong demand for the company's diversified product portfolio, which includes annuity, health, and life insurance offerings catering to the growing needs of the middle-income market.

AI Analysis | Feedback

Share Repurchases

  • CNO Financial repurchased $60.0 million of common stock in Q3 2025, buying 1.6 million shares at an average cost of $38.19 per share.
  • As of September 30, 2025, the company had authority to repurchase up to an additional $480.4 million of common stock.
  • In Q2 2025, CNO repurchased $100 million in shares, contributing to a year-to-date total of $234 million in shareholder returns, and had an authorization of approximately $540.4 million remaining as of June 30, 2025.
  • For the full year 2024, CNO returned $349 million to shareholders, a 50% increase from 2023. In February 2025, the Board approved an additional $500 million for share repurchases, adding to the $240.3 million remaining capacity as of December 31, 2024.
  • In 2023, CNO returned more than $230 million to shareholders.
  • In 2022, CNO returned $245 million to shareholders in the form of share repurchases and dividends, with $10.0 million in share repurchases in Q4 2022.
  • In 2021, the company returned $468.1 million to shareholders, which included a record $402.4 million in share repurchases. In May 2021, an additional $500 million was approved for share repurchases, adding to approximately $169 million remaining capacity as of March 31, 2021.
  • In 2020, CNO repurchased 14.5 million shares for $263.0 million, and had remaining repurchase authority of $269.3 million as of December 31, 2020.

Share Issuance

  • As of September 30, 2025, CNO Financial had 95.8 million shares outstanding. This is a decrease from 98.6 million weighted average diluted shares outstanding in Q3 2025.
  • Weighted average diluted shares outstanding decreased by 7% from Q4 2021 to Q4 2022.

Outbound Investments

  • In October 2025, CNO decided to streamline its Worksite Division operations by exiting the fee services side of the business, which included services acquired in the Web Benefits Design and DirectPath acquisitions. This exit is expected to be substantially complete in the first half of 2026.

Capital Expenditures

  • CNO generally balances growth investments and technology expenditures against operating efficiency. The company continues to invest in technology and sales tools to support operational efficiency.

Trade Ideas

Select ideas related to CNO.

Unique KeyDateTickerCompanyCategoryTrade Strategy6M Fwd Rtn12M Fwd Rtn12M Max DD
NDAQ_2282026_Insider_Buying_45D_2Buy_200K02282026NDAQNasdaqInsiderInsider Buys 45DStrong Insider Buying
Companies with multiple insider buys in the last 45 days
0.0%0.0%0.0%
JEF_2272026_Dip_Buyer_ValueBuy02272026JEFJefferies FinancialDip BuyDB | P/E OPMDip Buy with Low PE and High Margin
Buying dips for companies with tame PE and meaningfully high operating margin
0.0%0.0%0.0%
PAYO_2272026_Dip_Buyer_High_CFO_Margins_ExInd_DE02272026PAYOPayoneer GlobalDip BuyDB | CFO/Rev | Low D/EDip Buy with High Cash Flow Margins
Buying dips for companies with significant cash flows from operations and reasonable debt / market cap
0.0%0.0%0.0%
FOUR_2272026_Dip_Buyer_High_FCF_Yield_ExInd_DE_RevG02272026FOURShift4 PaymentsDip BuyDB | FCF Yield | Low D/EDip Buy with High Free Cash Flow Yield
Buying dips for companies with significant free cash flow yield (FCF / Market Cap) and reasonable debt / market cap
0.0%0.0%0.0%
COIN_2202026_Dip_Buyer_High_CFO_Margins_ExInd_DE02202026COINCoinbase GlobalDip BuyDB | CFO/Rev | Low D/EDip Buy with High Cash Flow Margins
Buying dips for companies with significant cash flows from operations and reasonable debt / market cap
2.6%2.6%-6.5%

Recent Active Movers

Peer Comparisons

Peers to compare with:

Financials

CNOGLAFLUNMPRIKMPRMedian
NameCNO Fina.Globe Li.Aflac Unum PrimericaKemper  
Mkt Price39.77138.77109.6372.69249.0629.1491.16
Mkt Cap3.811.057.012.28.01.79.5
Rev LTM4,4875,99417,35512,9873,2924,7835,389
Op Inc LTM-------
FCF LTM6761,2542,555555875554775
FCF 3Y Avg6291,3392,8171,004789232896
CFO LTM6761,3962,555688901584794
CFO 3Y Avg6291,4272,8171,135819278977

Growth & Margins

CNOGLAFLUNMPRIKMPRMedian
NameCNO Fina.Globe Li.Aflac Unum PrimericaKemper  
Rev Chg LTM0.9%3.7%-9.3%1.5%6.6%3.2%2.4%
Rev Chg 3Y Avg8.0%4.8%-3.1%3.0%7.4%-4.1%3.9%
Rev Chg Q4.2%3.6%-11.0%0.1%8.3%-4.5%1.9%
QoQ Delta Rev Chg LTM1.0%0.9%-3.4%0.0%2.0%-1.1%0.5%
Op Mgn LTM-------
Op Mgn 3Y Avg-------
QoQ Delta Op Mgn LTM-------
CFO/Rev LTM15.1%23.3%14.7%5.3%27.4%12.2%14.9%
CFO/Rev 3Y Avg14.4%25.3%15.3%9.0%26.7%5.9%14.8%
FCF/Rev LTM15.1%20.9%14.7%4.3%26.6%11.6%14.9%
FCF/Rev 3Y Avg14.4%23.8%15.3%7.9%25.7%5.0%14.8%

Valuation

CNOGLAFLUNMPRIKMPRMedian
NameCNO Fina.Globe Li.Aflac Unum PrimericaKemper  
Mkt Cap3.811.057.012.28.01.79.5
P/S0.81.83.30.92.40.41.4
P/EBIT7.47.012.010.78.08.68.3
P/E17.19.515.616.510.612.013.8
P/CFO5.67.922.317.78.82.98.4
Total Yield7.6%11.3%8.5%8.6%11.1%13.0%9.9%
Dividend Yield1.7%0.8%2.1%2.5%1.7%4.6%1.9%
FCF Yield 3Y Avg17.3%12.7%5.3%9.0%9.6%8.3%9.3%
D/E1.10.20.10.30.20.60.3
Net D/E-1.2-1.4-1.1-2.7-0.00.3-1.1

Returns

CNOGLAFLUNMPRIKMPRMedian
NameCNO Fina.Globe Li.Aflac Unum PrimericaKemper  
1M Rtn-7.2%-2.2%-4.9%1.3%-5.6%-9.4%-5.2%
3M Rtn-2.9%0.0%1.3%-4.4%-2.2%-27.9%-2.6%
6M Rtn1.4%-2.2%1.9%-2.2%-8.5%-44.6%-2.2%
12M Rtn3.5%14.4%7.0%-4.2%-8.8%-54.1%-0.3%
3Y Rtn98.3%33.3%88.3%115.2%60.2%-43.4%74.3%
1M Excs Rtn-4.8%0.2%-2.5%3.7%-3.2%-7.0%-2.8%
3M Excs Rtn1.1%5.4%3.0%0.6%-0.1%-25.2%0.9%
6M Excs Rtn-1.5%-3.5%-0.4%-3.9%-10.6%-47.7%-3.7%
12M Excs Rtn-17.6%-9.3%-16.2%-27.0%-30.4%-75.6%-22.3%
3Y Excs Rtn-1.4%-51.3%4.6%4.5%-26.1%-117.7%-13.8%

Comparison Analyses

null

Financials

Segment Financials

Assets by Segment
$ Mil20252024202320222021
Annuity13,00612,00610,97113,28913,074
Investments not allocated to product lines10,5988,7128,8577,0936,426
Health9,1179,5129,02010,55910,931
Life4,1954,1543,7844,6864,422
Assets of our other non-life companies680399293384371
Assets of our non-life companies included in the fee income segment258244208194117
Total37,85335,02733,13336,20435,340


Price Behavior

Price Behavior
Market Price$39.77 
Market Cap ($ Bil)3.8 
First Trading Date09/10/2003 
Distance from 52W High-10.5% 
   50 Days200 Days
DMA Price$42.07$39.59
DMA Trendupup
Distance from DMA-5.5%0.5%
 3M1YR
Volatility26.0%28.6%
Downside Capture66.6889.18
Upside Capture62.0175.78
Correlation (SPY)43.4%65.8%
CNO Betas & Captures as of 2/28/2026

 1M2M3M6M1Y3Y
Beta1.401.261.080.670.991.03
Up Beta3.483.373.121.631.021.08
Down Beta1.231.161.050.591.181.08
Up Capture108%59%60%45%65%93%
Bmk +ve Days9203170142431
Stock +ve Days13203270140406
Down Capture62%81%48%43%91%99%
Bmk -ve Days12213054109320
Stock -ve Days8202852109338

[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively
Based On 1-Year Data
Annualized
Return
Annualized
Volatility
Sharpe
Ratio
Correlation
with CNO
CNO4.0%28.5%0.13-
Sector ETF (XLF)3.6%19.3%0.0677.7%
Equity (SPY)21.0%18.9%0.8765.7%
Gold (GLD)74.9%26.2%2.12-4.0%
Commodities (DBC)19.3%17.2%0.8918.9%
Real Estate (VNQ)5.7%16.3%0.1658.1%
Bitcoin (BTCUSD)-16.1%44.2%-0.2725.6%

Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 5-Year Data
Annualized
Return
Annualized
Volatility
Sharpe
Ratio
Correlation
with CNO
CNO12.7%28.9%0.44-
Sector ETF (XLF)9.5%18.7%0.3975.3%
Equity (SPY)13.2%17.0%0.6157.0%
Gold (GLD)24.2%17.3%1.141.6%
Commodities (DBC)10.9%19.0%0.4616.0%
Real Estate (VNQ)5.0%18.8%0.1748.3%
Bitcoin (BTCUSD)7.3%56.8%0.3517.4%

Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 10-Year Data
Annualized
Return
Annualized
Volatility
Sharpe
Ratio
Correlation
with CNO
CNO10.5%34.5%0.38-
Sector ETF (XLF)12.5%22.2%0.5280.3%
Equity (SPY)14.7%17.9%0.7066.7%
Gold (GLD)14.6%15.6%0.77-3.0%
Commodities (DBC)8.8%17.6%0.4126.0%
Real Estate (VNQ)5.5%20.7%0.2356.5%
Bitcoin (BTCUSD)66.7%66.8%1.0615.3%

Smart multi-asset allocation framework can stack odds in your favor. Learn How

Short Interest

Short Interest: As Of Date2272026
Short Interest: Shares Quantity1.9 Mil
Short Interest: % Change Since 2152026-6.2%
Average Daily Volume0.8 Mil
Days-to-Cover Short Interest2.4 days
Basic Shares Quantity95.1 Mil
Short % of Basic Shares2.0%

Earnings Returns History

Expand for More
 Forward Returns
Earnings Date1D Returns5D Returns21D Returns
2/5/20265.5%2.1%-2.3%
11/3/20254.3%3.3%1.8%
7/28/2025-1.6%-4.6%4.4%
4/28/2025-4.8%-6.4%-6.2%
2/6/20252.6%3.7%-3.1%
10/31/20244.4%12.0%14.4%
7/29/202410.7%2.1%9.2%
4/29/2024-2.1%3.0%2.7%
...
SUMMARY STATS   
# Positive131214
# Negative111210
Median Positive2.8%2.6%7.8%
Median Negative-4.0%-2.7%-6.4%
Max Positive10.7%12.1%20.5%
Max Negative-11.0%-12.6%-14.7%

SEC Filings

Expand for More
Report DateFiling DateFiling
12/31/202502/24/202610-K
09/30/202511/06/202510-Q
06/30/202508/06/202510-Q
03/31/202505/07/202510-Q
12/31/202402/26/202510-K
09/30/202411/07/202410-Q
06/30/202408/09/202410-Q
03/31/202405/06/202410-Q
12/31/202302/23/202410-K
09/30/202311/08/202310-Q
06/30/202308/09/202310-Q
03/31/202305/10/202310-Q
12/31/202202/24/202310-K
09/30/202211/04/202210-Q
06/30/202208/05/202210-Q
03/31/202205/06/202210-Q

Insider Activity

Expand for More
#OwnerTitleHoldingActionFiling DatePriceSharesTransacted
Value
Value of
Held Shares
Form
1Bhojwani, Gary CChief Executive OfficerDirectSell102202641.9931,4301,319,6398,226,267Form
2Tarasi, Rocco F IiiChief Marketing OfficerDirectSell1215202542.609,283395,4393,149,367Form
3Franzese, Yvonne KChief Human Resources OfficerDirectSell1125202541.003,000123,000886,297Form
4Bhojwani, Gary CChief Executive OfficerDirectSell1121202539.9731,4301,256,3429,088,033Form
5Johnson, Eric RChief Investment OfficerDirectSell1113202541.2448,6652,007,01327,695,332Form